(Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo

Finbarr O'Harte, BD Green, Victor Gault, Nigel Irwin, MH Mooney, P Harriott, B Greer, Peter Flatt

Research output: Contribution to journalArticle

LanguageEnglish
Pages43-43
JournalDiabetic medicine
Volume21 (S2
Publication statusPublished - 2004

Cite this

@article{32abffc02ca9460582fc3c3e72a00c79,
title = "(Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo",
author = "Finbarr O'Harte and BD Green and Victor Gault and Nigel Irwin and MH Mooney and P Harriott and B Greer and Peter Flatt",
year = "2004",
language = "English",
volume = "21 (S2",
pages = "43--43",
journal = "Diabetes Medicine",
issn = "0742-3071",

}

(Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo. / O'Harte, Finbarr; Green, BD; Gault, Victor; Irwin, Nigel; Mooney, MH; Harriott, P; Greer, B; Flatt, Peter.

In: Diabetic medicine, Vol. 21 (S2, 2004, p. 43-43.

Research output: Contribution to journalArticle

TY - JOUR

T1 - (Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo

AU - O'Harte, Finbarr

AU - Green, BD

AU - Gault, Victor

AU - Irwin, Nigel

AU - Mooney, MH

AU - Harriott, P

AU - Greer, B

AU - Flatt, Peter

PY - 2004

Y1 - 2004

M3 - Article

VL - 21 (S2

SP - 43

EP - 43

JO - Diabetes Medicine

T2 - Diabetes Medicine

JF - Diabetes Medicine

SN - 0742-3071

ER -